North Dakota State Investment Board’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.2M Buy
23,539
+325
+1% +$332K 1.15% 14
2026
Q1
$21.4M Sell
23,214
-4,268
-16% -$4.33M 0.92% 17
2025
Q4
$29.5M Buy
+27,482
New +$26.3M 1.1% 16

Other funds holding LLY

North Dakota State Investment Board's LLY Position: Q2 2026 in Review

North Dakota State Investment Board increased its Eli Lilly (LLY) stake by 1.4% in Q2 2026, buying an estimated $332K and bringing the position to 23,539 shares worth $28.2M. The position accounts for 1.15% of the portfolio, ranked #14.

North Dakota State Investment Board first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $29.5M in Q4 2025. 4,646 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • North Dakota State Investment Board held 23,539 shares of Eli Lilly worth $28.2M as of Q2 2026.
  • North Dakota State Investment Board bought 325 Eli Lilly shares in Q2 2026, an estimated $332K.
  • Eli Lilly made up 1.15% of North Dakota State Investment Board's portfolio in Q2 2026, its #14 holding.
  • North Dakota State Investment Board first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's Eli Lilly position peaked at $29.5M in Q4 2025.
  • 4,646 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.